Maternal cardiometabolic markers are associated with fetal growth: a secondary exploratory analysis of the LIMIT randomised trial

Background To determine the association between maternal cardiometabolic and inflammatory markers with measures of fetal biometry and adiposity. Methods Women included in this exploratory analysis were randomised to the ‘Standard Care’ group ( N = 911) from the LIMIT randomised trial involving a total of 2212 pregnant women who were overweight or obese (ACTRN12607000161426, Date of registration 9/03/2007, prospectively registered). Fetal...